Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
A novel frameshift pathogenic variant in ST3GAL5 causing salt and pepper developmental regression syndrome (SPDRS): A case report.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Early growth and development impairment in patients with ganglioside GM3 synthase deficiency.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Etiology of vision loss in ganglioside GM3 synthase deficiency.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Oral Ganglioside Supplement Improves Growth and Development in Patients with Ganglioside GM3 Synthase Deficiency.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Quantification of monosialogangliosides in human plasma through chemical derivatization for signal enhancement in LC-ESI-MS.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.
(n-acetylneuraminyl)-galactosylglucosylceramide n-acetylgalactosaminyltransferase deficiency
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.
Adenocarcinoma
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
Atherosclerosis
[Activation of ganglioside GM3 biosynthesis in human blood mononuclear cells in atherosclerosis].
Breast Neoplasms
Endothelial ganglioside GM3 regulates angiogenesis in solid tumors.
Breast Neoplasms
Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Breast Neoplasms
Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells.
Carcinoma
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.
Carcinoma
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Carcinoma
Curcumin Downregulates Human GM3 Synthase (hST3Gal V) Gene Expression with Autophagy Induction in Human Colon Carcinoma HCT116 Cells.
Carcinoma
Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Carcinoma
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 up-regulation in human ovarian carcinoma cells.
Carcinoma
Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells.
Carcinoma, Hepatocellular
beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F.
Carcinoma, Lewis Lung
Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Carcinoma, Lewis Lung
Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells.
Carcinoma, Non-Small-Cell Lung
GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Carcinoma, Squamous Cell
Induction of GM3 expression by valproic acid suppresses cancer cell growth.
Congenital Disorders of Glycosylation
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation.
Deafness
Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells.
Deafness
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.
Demyelinating Diseases
Inhibition of GM3 Synthase Attenuates Neuropathology of Niemann-Pick Disease Type C by Affecting Sphingolipid Metabolism.
Diabetic Foot
Ganglioside GM3 Depletion Reverses Impaired Wound Healing in Diabetic Mice by Activating IGF-1 and Insulin Receptors.
Drug Resistant Epilepsy
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.
Encephalomyelitis
Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis.
Epilepsy
Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options.
Epilepsy
[Advances in the studies on the molecular and genetic aspects of epilepsy]
Epileptic Syndromes
Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.
Epileptic Syndromes
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.
Epileptic Syndromes
Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.
Fatty Liver
Limited Therapeutic Effect of N-Acetylcysteine on Hepatic Insulin Resistance in an Experimental Model of Alcohol-Induced Steatohepatitis.
Gastrointestinal Neoplasms
Decreased expression of alpha2,8 sialyltransferase and increased expression of beta1,4 N-acetylgalactosaminyltransferase in gastrointestinal cancers.
Gastrointestinal Neoplasms
Enhanced expression of GM2/GD2 synthase mRNA in human gastrointestinal cancer.
Genetic Diseases, Inborn
A novel frameshift pathogenic variant in ST3GAL5 causing salt and pepper developmental regression syndrome (SPDRS): A case report.
Herpes Simplex
N-acetylgalactosaminyltransferase activity involved in O-glycosylation of herpes simplex virus type 1 glycoproteins.
Infertility, Male
Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting.
Insulin Resistance
Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors.
Insulin Resistance
Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy mice.
Insulin Resistance
Ganglioside GM3 participates in the pathological conditions of insulin resistance.
Intellectual Disability
ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.
Leukemia
Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units.
Leukemia
Involvement of CREB in the transcriptional regulation of the human GM3 synthase (hST3Gal V) gene during megakaryocytoid differentiation of human leukemia K562 cells.
Leukemia
Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells.
Leukemia
Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells.
Leukemia
Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation.
Leukemia, T-Cell
Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units.
Lung Neoplasms
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Lung Neoplasms
GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Lung Neoplasms
Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene.
Malnutrition
Undernutrition changes GD3 and GM2 synthase activities in developing rat hypothalamus.
Medulloblastoma
[Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content]
Melanoma
Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile.
Melanoma
Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).
Melanoma
Expression cloning of rat cDNA encoding UDP-galactose:GD2 beta1,3-galactosyltransferase that determines the expression of GD1b/GM1/GA1.
Melanoma
Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units.
Melanoma
Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma.
Melanoma
UVB-irradiated keratinocytes induce melanoma-associated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor ? and interleukin 6.
Melanoma, Experimental
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody.
Neoplasm Metastasis
Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Neoplasm Metastasis
Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells.
Neoplasm Metastasis
Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene.
Neoplasm, Residual
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
Neoplasm, Residual
Useful markers for detecting minimal residual disease in cases of neuroblastoma.
Neoplasms
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.
Neoplasms
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Neoplasms
Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).
Neoplasms
Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR.
Neoplasms
Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.
Neoplasms
Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Neoplasms
Ganglioside GM3 participates in the pathological conditions of insulin resistance.
Neoplasms
GD2 synthase: a new molecular marker for detecting neuroblastoma.
Neoplasms
Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
Neoplasms
Glycolipid composition in bladder tumor: a crucial role of GM3 ganglioside in tumor invasion.
Neoplasms
GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
Neoplasms
Induction of GM3 expression by valproic acid suppresses cancer cell growth.
Neoplasms
Introduction of Sd(a) carbohydrate antigen in gastrointestinal cancer cells eliminates selectin ligands and inhibits metastasis.
Neoplasms
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody.
Neoplasms
Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Neoplasms
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma.
Neoplasms
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.
Neoplasms
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.
Neoplasms
Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
Neoplasms
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
Neoplasms
Suppression of vascular smooth muscle cell responses induced by TNF-? in GM3 synthase gene transfected cells.
Neoplasms
TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells.
Neoplasms
TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.
Neoplasms
[Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content]
Neuralgia
Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice.
Neuroblastoma
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Neuroblastoma
Changes in the ganglioside composition of human neuroblastoma cells under different growth conditions.
Neuroblastoma
Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR.
Neuroblastoma
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.
Neuroblastoma
Effect of N-glycosylation on turnover and subcellular distribution of N-acetylgalactosaminyltransferase I and sialyltransferase II in neuroblastoma cells.
Neuroblastoma
GD2 synthase: a new molecular marker for detecting neuroblastoma.
Neuroblastoma
Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units.
Neuroblastoma
Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Neuroblastoma
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
Neuroblastoma
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma.
Neuroblastoma
Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.
Neuroblastoma
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Neuroblastoma
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
Neuroblastoma
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.
Neuroblastoma
Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
Neuroblastoma
Valproic acid-mediated transcriptional regulation of human GM3 synthase (hST3Gal V) in SK-N-BE(2)-C human neuroblastoma cells.
Niemann-Pick Disease, Type C
Inhibition of GM3 Synthase Attenuates Neuropathology of Niemann-Pick Disease Type C by Affecting Sphingolipid Metabolism.
Niemann-Pick Diseases
Inhibition of GM3 Synthase Attenuates Neuropathology of Niemann-Pick Disease Type C by Affecting Sphingolipid Metabolism.
Osteoarthritis
Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis.
Ovarian Neoplasms
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.
Ovarian Neoplasms
Human GM3 Synthase Attenuates Taxol-Triggered Apoptosis Associated with Downregulation of Caspase-3 in Ovarian Cancer Cells.
Polycystic Kidney Diseases
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease.
Prion Diseases
Ganglioside Synthase Knockout Reduces Prion Disease Incubation Time in Mouse Models.
Retinoblastoma
Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA.
Retinoblastoma
Minimally disseminated disease and outcome in overt orbital retinoblastoma.
Retinoblastoma
Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma.
Scrapie
Ganglioside Synthase Knockout Reduces Prion Disease Incubation Time in Mouse Models.
Small Cell Lung Carcinoma
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Spastic Paraplegia, Hereditary
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
Urinary Bladder, Neurogenic
Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.
Urinary Bladder, Overactive
Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Senn, H.J.; Cooper, C.; Warnke, P.C.; Wagner, M.; Decker, K.
Ganglioside biosynthesis in rat liver. Characterization of UDP-N-acetylgalactosamine - GM3 acetylgalactosaminyltransferase
Eur. J. Biochem.
120
59-67
1981
Homo sapiens, Rattus norvegicus
brenda
Nagata, Y.; Yamashiro, S.; Yodoi, J.; Lloyd, K.O.; Shiku, H.; Furukawa, K.
Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides [published erratum appears in J Biol Chem 1994 Mar 4;269(9):7045]
J. Biol. Chem.
267
12082-12089
1992
Homo sapiens
brenda
Jaskiewicz, E.; Zhu, G.; Taatjes, D.J.; Darling, D.S.; Zwanzig, G.E., Jr.; Young, W.W., Jr.
Cloned beta1,4N-acetylgalactosaminyltransferase: subcellular localization and formation of disulfide bonded species
Glycoconjugate J.
13
213-223
1996
Homo sapiens (Q00973), Homo sapiens
brenda
Zhu, G.; Jaskiewicz, E.; Bassi, R.; Darling, D.S.; Young, W.W., Jr.
beta1,4 N-Acetylgalactosaminyltransferase (GM2/GD2/GA2 synthase) forms homodimers in the endoplasmic reticulum: a strategy to test for dimerization of Golgi membrane proteins
Glycobiology
7
987-996
1997
Homo sapiens (Q00973)
brenda
Haraguchi, M.; Yamashiro, S.; Furukawa, K.; Takamiya, K.; Shiku, H.; Furukawa, K.
The effects of the site-directed removal of N-glycosylation sites from beta-1,4-N-acetylgalactosaminyltransferase on its function
Biochem. J.
312
273-280
1995
Homo sapiens (Q00973)
-
brenda
Ruan, S.; Raj, B.K.M.; Furukawa, K.; Lloyd, K.O.
Analysis of melanoma cells stably transfected with b1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression
Arch. Biochem. Biophys.
323
11-18
1995
Homo sapiens (Q00973)
brenda
Furukawa, K.; Takamiya, K.; Furukawa, K.
beta1,4-N-acetylgalactosaminyltransferase-GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides
Biochim. Biophys. Acta
1573
356-362
2002
Homo sapiens (Q00973), Mus musculus (Q09200)
brenda
Daniotti, J.L.; Martina, J.A.; Giraudo, C.G.; Zurita, A.R.; Maccioni, H.J.F.
GM3 alpha2,8-sialyltransferase (GD3 synthase): protein characterization and sub-Golgi location in CHO-K1 cells
J. Neurochem.
74
1711-1720
2000
Homo sapiens
brenda
Li, J.; Rancour, D.M.; Allende, M.L.; Worth, C.A.; Darling, D.S.; Gilbert, J.B.; Menon, A.K.; Young, W.W., Jr.
The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding
Glycobiology
11
217-229
2001
Homo sapiens (Q00973)
brenda
Gotoh, M.; Sato, T.; Kiyohara, K.; Kameyama, A.; Kikuchi, N.; Kwon, Y.D.; Ishizuka, Y.; Iwai, T.; Nakanishi, H.; Narimatsu, H.
Molecular cloning and characterization of beta1,4-N-acetylgalactosaminyltransferases IV synthesizing N,N'-diacetyllactosediamine
FEBS Lett.
562
134-140
2004
Homo sapiens (Q76KP1)
brenda
Ramakrishnan, B.; Qasba, P.K.
Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates
J. Mol. Biol.
365
570-576
2007
Drosophila melanogaster, Homo sapiens
brenda
Martinez, C.; Hofmann, T.J.; Marino, R.; Dominici, M.; Horwitz, E.M.
Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs
Blood
109
4245-4248
2007
Homo sapiens (Q00973), Homo sapiens
brenda
Wang, H.R.; Hsieh, C.Y.; Twu, Y.C.; Yu, L.C.
Expression of the human Sda beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status
Glycobiology
18
104-113
2008
Homo sapiens
brenda
Ootsuka, S.; Asami, S.; Sasaki, T.; Yoshida, Y.; Nemoto, N.; Shichino, H.; Chin, M.; Mugishima, H.; Suzuki, T.
Useful markers for detecting minimal residual disease in cases of neuroblastoma
Biol. Pharm. Bull.
31
1071-1074
2008
Homo sapiens
brenda
Prinetti, A.; Aureli, M.; Illuzzi, G.; Prioni, S.; Nocco, V.; Scandroglio, F.; Gagliano, N.; Tredici, G.; Rodriguez-Menendez, V.; Chigorno, V.; Sonnino, S.
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells
Glycobiology
20
62-77
2010
Homo sapiens
brenda
Chen, L.C.; Brown, A.B.; Cheung, I.Y.; Cheung, N.K.; Kris, M.G.; Krug, L.M.
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer
Lung Cancer
67
216-220
2010
Homo sapiens
brenda
Song, N.; Kim, S.J.; Kwon, H.Y.; Son, S.W.; Kim, K.S.; Ahn, H.B.; Lee, Y.C.
Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells
BMB Rep.
44
405-409
2011
Homo sapiens
brenda
Miyata, M.; Ichihara, M.; Tajima, O.; Sobue, S.; Kambe, M.; Sugiura, K.; Furukawa, K.; Furukawa, K.
UVB-irradiated keratinocytes induce melanoma-associated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor alpha and interleukin 6
Biochem. Biophys. Res. Commun.
445
504-510
2014
Homo sapiens (Q00973)
brenda
Harlalka, G.V.; Lehman, A.; Chioza, B.; Baple, E.L.; Maroofian, R.; Cross, H.; Sreekantan-Nair, A.; Priestman, D.A.; Al-Turki, S.; McEntagart, M.E.; Proukakis, C.; Royle, L.; Kozak, R.P.; Bastaki, L.; Patton, M.; Wagner, K.; Coblentz, R.; Price, J.; Mezei, M.; Schlade-Bartusiak, K.; Platt, F.M.; Hurle, M.E.; Crosby, A.H.
Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
Brain
136
3618-3624
2013
Homo sapiens (Q00973)
brenda